Pfizer announced it has developed a vaccine for the youngest among us (6 mos. to 5 years) and is waiting on approval from the FDA. The shots will be a two-dose regimen.
Dr. Scott Gottlieb, a former FDA commissioner and current Pfizer board member applauded the move.
“If the goal of the vaccine is to get baseline immunity in the kids – to prevent really bad outcomes and you’re really not using the vaccine as a tool to prevent infection in the first place – two doses could do that,” Gottlieb said on CBS’ Face the Nation.
As more young children fall prey to the virus, this is welcome news for parents.
